Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test-Reference-Cited by-同舟云学术

Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test

Published:2001-06 Issue:6 Volume:41 Page:771-774
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kurz Martin,Knobl Paul,Kalhs Peter,Greinix Hildegard T.,Hocker Paul,Panzer Simon

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1537-2995.2001.41060771.x/fullpdf

Reference19 articles.

1. The Challenge of Platelet Alloimmunization: Management and Prevention

2. Factors influencing 20-hour increments after platelet transfusion

3. Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization

4. Influence of antibiotics on posttransfusion platelet increment

5. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the correlation between platelet antibodies and peripheral blood cytopenia in patients with hepatocellular carcinoma;Scientific Reports;2024-04-27

2. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia;British Journal of Haematology;2020-01-29

3. Allogeneic major histocompatibility complex antigens are necessary and sufficient for partial tolerance induced by transfusion of pathogen reduced platelets in mice;Vox Sanguinis;2019-02-07

4. Human Leucocyte Antigen Sensitisation and Its Impact on Transfusion Practice;Transfusion Medicine and Hemotherapy;2019

5. Platelet component transfusion and alloimmunization: Where do we stand?;Transfusion Clinique et Biologique;2018-09